DE69605899D1 - Gel zur lokalen hormontherapie der vaginalen trockenheit - Google Patents

Gel zur lokalen hormontherapie der vaginalen trockenheit

Info

Publication number
DE69605899D1
DE69605899D1 DE69605899T DE69605899T DE69605899D1 DE 69605899 D1 DE69605899 D1 DE 69605899D1 DE 69605899 T DE69605899 T DE 69605899T DE 69605899 T DE69605899 T DE 69605899T DE 69605899 D1 DE69605899 D1 DE 69605899D1
Authority
DE
Germany
Prior art keywords
gel
oestrogen
estradiol
beta
vaginal dryness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69605899T
Other languages
English (en)
Other versions
DE69605899T2 (de
Inventor
Catherine Meignant
Corinne Vieillard-Baron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Publication of DE69605899D1 publication Critical patent/DE69605899D1/de
Application granted granted Critical
Publication of DE69605899T2 publication Critical patent/DE69605899T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DE69605899T 1995-10-05 1996-10-04 Gel zur lokalen hormontherapie der vaginalen trockenheit Expired - Fee Related DE69605899T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511731A FR2739559B1 (fr) 1995-10-05 1995-10-05 Gel pour hormonotherapie locale de la secheresse vaginale
PCT/FR1996/001556 WO1997012618A1 (fr) 1995-10-05 1996-10-04 Gel pour hormonotherapie locale de la secheresse vaginale

Publications (2)

Publication Number Publication Date
DE69605899D1 true DE69605899D1 (de) 2000-02-03
DE69605899T2 DE69605899T2 (de) 2000-07-27

Family

ID=9483282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69605899T Expired - Fee Related DE69605899T2 (de) 1995-10-05 1996-10-04 Gel zur lokalen hormontherapie der vaginalen trockenheit

Country Status (10)

Country Link
EP (1) EP0813412B1 (de)
JP (1) JPH11512732A (de)
CN (1) CN1198672A (de)
AT (1) ATE188120T1 (de)
AU (1) AU7220596A (de)
CA (1) CA2233923A1 (de)
DE (1) DE69605899T2 (de)
ES (1) ES2143230T3 (de)
FR (1) FR2739559B1 (de)
WO (1) WO1997012618A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005408B2 (en) 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
CN101232869B (zh) * 2005-06-16 2016-03-02 沃纳奇尔科特有限责任公司 局部给药的凝胶组合物
US10016442B2 (en) * 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
AR056453A1 (es) * 2005-08-12 2007-10-10 Drug Tech Corp Composiciones con estrogeno y metodos terapeuticos para su uso
EP1890704A1 (de) * 2005-12-16 2008-02-27 Lyle Corporate Development, Inc. Wiederherstellung von vaginalgewebe durch nicht-systemische vaginale verabreichung von östrogen
WO2013012430A1 (en) * 2011-07-19 2013-01-24 Riepl Michael S Dhea bioadhesive controlled release gel
US9320744B2 (en) 2011-10-19 2016-04-26 Dhea Llc DHEA bioadhesive controlled release gel
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
CN104117135A (zh) * 2014-08-11 2014-10-29 崔仁海 阴道内植入式治疗装置
EP4091601A1 (de) * 2016-01-07 2022-11-23 Viramal Limited Gelzusammensetzungen zur transdermalen verabreichung zur maximierung der arzneimittelkonzentration in der stratum corneum und serum und verfahren zur verwendung davon
SE1750680A1 (en) * 2017-05-30 2018-12-01 Peptonic Medical Ab Composition for treating or preventing climacteric disorders
CN113164384A (zh) 2018-10-26 2021-07-23 维拉莫有限公司 黏膜粘附性凝胶组合物
EP3659583B1 (de) 2018-11-30 2023-06-07 Viramal Limited Verfahren zur herstellung eines geliermittels, das dadurch erhaltene geliermittel und verwendung dieses geliermittels
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN114588252A (zh) * 2022-04-08 2022-06-07 暨南大学附属第一医院（广州华侨医院） 一种用于缓解阴道萎缩和干燥症的组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JP3131667B2 (ja) * 1992-09-07 2001-02-05 光洋精工株式会社 トルクセンサ
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis

Also Published As

Publication number Publication date
FR2739559A1 (fr) 1997-04-11
ES2143230T3 (es) 2000-05-01
EP0813412B1 (de) 1999-12-29
CA2233923A1 (fr) 1997-04-10
DE69605899T2 (de) 2000-07-27
CN1198672A (zh) 1998-11-11
WO1997012618A1 (fr) 1997-04-10
ATE188120T1 (de) 2000-01-15
AU7220596A (en) 1997-04-28
EP0813412A1 (de) 1997-12-29
FR2739559B1 (fr) 1997-11-28
JPH11512732A (ja) 1999-11-02

Similar Documents

Publication Publication Date Title
DE69605899T2 (de) Gel zur lokalen hormontherapie der vaginalen trockenheit
AU776318B2 (en) Topical zinc compositions and methods of use
DE69620625D1 (de) Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit
EP0189738B1 (de) Topische Mittel zur Verhütung oder Behandlung trockener Haut
US4837378A (en) Topical metronidazole formulations and therapeutic uses thereof
ES2330096T3 (es) Composiciones lubricantes que producen calor, no irritantes.
US7048951B1 (en) Systems and methods for topical treatment with nitric oxide
US6723345B2 (en) Topical drug preparations
US9023392B2 (en) Methods of administering a dermatological agent to a subject
US4500511A (en) Antiinflammatory and analgesic gel
US6387407B1 (en) Topical drug preparations
EP0305380A1 (de) Neue topische metronidazol-formulierungen.
KR20050025166A (ko) 가온성 및 무자극성 윤활제 항진균성 겔 조성물
JPH08175986A (ja) 経皮活性を示す５−アミノレブリン酸含有薬学組成物
JPS5988421A (ja) 皮脂の広がりの減少組成物
CA2390841A1 (en) Drug preparations
CA2056392A1 (en) Topical treatment of herpesvirus hominis
Turner et al. Trade Names Index
RU98108031A (ru) Гель для местной гормонотерапии сухости влагалища
NZ210943A (en) Dehydroepiandrosterone compositons for skin treatment
MXPA00005595A (en) Topical zinc compositions and methods of use
CZ5827U1 (cs) Analgetlcký přípravek s protizánětlivým a antiseptickým účinkem
CZ353292A3 (en) Analgesic preparation exhibiting antiphlogistic, antiseptic a healing activity.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee